bharat biotech
-
Covid-19
India’s First Intranasal Vaccine For Covid Gets DCGI Approval
New Delhi, Sep 6: India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller…
Read More » -
Covid-19
Sigh Of Relief: Bharat Biotech’s Covaxin Gets DCGI Nod For Children Between 6-12 Yrs
New Delhi, Apr 26: Covaxin, one of the main vaccines administered to adults in India, is currently being administered to…
Read More » -
Covid-19
ICMR Got Rs. 172 Crore Royalty From Sale Of Covaxin From Bharat Biotech
New Delhi, Feb 8: Indian Council of Medical Research (ICMR) has received royalty of Rs. 171.74 crore from Bharat Biotech…
Read More » -
Covid-19
DCGI Gives Green Signal To Bharat Biotech For Intranasal Vax Booster Trial
New Delhi: The Drugs Controller General of India (DCGI) on January 28 granted permission to Bharat Biotech to start conducting…
Read More »